In vitro release of adenosine triphosphate from the urothelium of human bladders with detrusor overactivity, both neurogenic and idiopathic.
about
Evidence for bladder urothelial pathophysiology in functional bladder disordersThe purinergic neurotransmitter revisited: a single substance or multiple players?How does the urothelium affect bladder function in health and disease? ICI-RS 2011Authentic role of ATP signaling in micturition reflex.Urothelial signaling.Effect of inflammatory mediators on ATP release of human urothelial RT4 cells.ATP during early bladder stretch is important for urgency in detrusor overactivity patientsExpression and distribution of ectonucleotidases in mouse urinary bladder.Detrusor underactivity: Pathophysiological considerations, models and proposals for future research. ICI-RS 2013.Pannexin 1 channels play essential roles in urothelial mechanotransduction and intercellular signalingReceptors, channels, and signalling in the urothelial sensory system in the bladderUrinary ATP may be a dynamic biomarker of detrusor overactivity in women with overactive bladder syndromePorcine bladder urothelial, myofibroblast, and detrusor muscle cells: characterization and ATP release.Simultaneous quantification of 12 different nucleotides and nucleosides released from renal epithelium and in human urine samples using ion-pair reversed-phase HPLCExtracellular UDP enhances P2X-mediated bladder smooth muscle contractility via P2Y(6) activation of the phospholipase C/inositol trisphosphate pathway.Diabetic plasticity of non-adrenergic non-cholinergic and P2X-mediated rat bladder contractionsPurinergic and muscarinic modulation of ATP release from the urothelium and its paracrine actions.Purinergic signalling in the urinary tract in health and disease.Non-invasive techniques in the diagnosis of bladder storage disorders.Chapter 2: Pathophysiology of neurogenic detrusor overactivity and the symptom complex of "overactive bladder".Recovery of urothelial mediator release but prolonged elevations in interleukin-8 and nitric oxide secretion following mitomycin C treatment.Urothelial ATP signaling: what is its role in bladder sensation?Human urothelial cell lines as potential models for studying cannabinoid and excitatory receptor interactions in the urinary bladder.Modulation of spontaneous activity in the overactive bladder: the role of P2Y agonists.Purinergic Signalling: Therapeutic Developments.ATP release from freshly isolated guinea-pig bladder urothelial cells: a quantification and study of the mechanisms involved.Correlation between cystometric volumes, ATP release, and pH in women with overactive bladder versus controls.The regulation of ATP release from the urothelium by adenosine and transepithelial potential.The role of ATP signalling in response to mechanical stimulation studied in T24 cells using new microphysiological tools.Proteomic analysis of urothelium of rats with detrusor overactivity induced by bladder outlet obstruction.Effect of short-term androgen deficiency on bladder contractility and urothelial mediator release.Increased Urinary Adenosine Triphosphate in Patients With Bladder Outlet Obstruction Due to Benign Prostate Hyperplasia.
P2860
Q26824708-8E68CACC-1EE9-4FEC-A823-BFE612A72DF9Q26824817-EEA738EF-2295-43D9-97C4-D15E4EAD26E6Q27010351-6DDE9E18-1B3D-48D4-A46D-1D23ADD20FC8Q27301269-A61CE107-4210-4E8C-AF76-1BD22DE350AEQ30440958-0D61E039-9105-494E-9185-EC3282EB5D4BQ33563019-10B9AABE-7DC0-47B6-8337-55157AF9332FQ33757819-3CBB5A87-0902-4B71-AE53-3077912BF099Q33886615-71A85AAC-03AA-483A-9D60-54B2A4B95267Q34074251-1FB4468D-BD09-49BB-8B53-13FB6D691FF9Q34110591-E485C70B-FDC8-416B-A506-B79D13A63993Q34516186-1FF3D261-2277-4D95-995F-B158D690B861Q34760718-985D4E4D-4818-49D9-BCDE-7054D90FAEE0Q35039656-82C4B948-34A2-4336-8EE9-1F2B3F7A678FQ36362898-D426E696-E219-4935-9FF8-FE867BF2F012Q36788773-EF671799-AE1C-45E1-AC15-90C62E21CF9DQ36925548-F71188DE-BE42-4AAD-A184-411429170E2DQ37575585-0596FF53-FA8E-48EE-AF08-82CBF96FB63DQ37620260-7356CE13-862F-42D5-8A60-3D8C5CA87903Q37903794-E89AE480-EB5C-4CA7-A28D-6E34A827D2D4Q38231747-C73D8505-70A7-4694-8B1D-6434C1419B3DQ38913866-811FC984-AA56-4D0D-9AB8-21E17206A05BQ38932041-1BF7569F-343F-44A0-B0FF-D2614CD17471Q39013400-7D79115D-9512-4266-A62E-093F742431D1Q42176404-FC14C90E-3529-44A3-B014-DBCC4C77335EQ42367885-F2986427-F4DF-4031-ACCA-EDA7DDB1BC10Q42467011-9832812E-F750-4DC7-ACCA-28E05EA35BFCQ44709382-9B4654D6-B47F-44CE-87DD-986C03A3FC35Q47279350-57A8DEB9-586A-4E76-87C3-BB024F5E4290Q48116918-4B4E88C9-EAE3-4C15-8A12-969B15047648Q48508163-8707C817-EECD-4E75-BFD3-3BA2E1430695Q50897539-7B65D45A-4F41-4793-957D-D5B0AED2990CQ53042842-0F68B949-6842-4D55-B5F4-1D6D74E4F9E2
P2860
In vitro release of adenosine triphosphate from the urothelium of human bladders with detrusor overactivity, both neurogenic and idiopathic.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
In vitro release of adenosine ...... oth neurogenic and idiopathic.
@en
In vitro release of adenosine ...... oth neurogenic and idiopathic.
@nl
type
label
In vitro release of adenosine ...... oth neurogenic and idiopathic.
@en
In vitro release of adenosine ...... oth neurogenic and idiopathic.
@nl
prefLabel
In vitro release of adenosine ...... oth neurogenic and idiopathic.
@en
In vitro release of adenosine ...... oth neurogenic and idiopathic.
@nl
P2093
P1433
P1476
In vitro release of adenosine ...... oth neurogenic and idiopathic.
@en
P2093
Derek Rosario
Paul R Tophill
Vivek Kumar
P304
P356
10.1016/J.EURURO.2009.11.042
P407
P577
2009-12-03T00:00:00Z